Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus A71 (EV-A71) VP3 is a capsid protein that contributes to the structural integrity of the virion. It is exposed on the surface of the virion and contains conserved epitopes, making it a target for diagnostic monoclonal antibodies like mAb 10D3 and therapeutic neutralizing antibodies like IgG 5H7. While VP1 is often the primary target for vaccines, VP3's conserved regions offer potential for cross-protective immunity against diverse EV-A71 strains.
Neutralizing antibody targeting conserved epitope at amino acid position 74
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A71 Capsid Protein VP3 (VP3).